These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 20056391)

  • 1. Cognitive remediation therapy in schizophrenia: cost-effectiveness analysis.
    Patel A; Knapp M; Romeo R; Reeder C; Matthiasson P; Everitt B; Wykes T
    Schizophr Res; 2010 Jul; 120(1-3):217-24. PubMed ID: 20056391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the potential cost-effectiveness of a vocational rehabilitation program for individuals with schizophrenia in a high-income welfare society.
    Evensen S; Wisløff T; Lystad JU; Bull H; Martinsen EW; Ueland T; Falkum E
    BMC Psychiatry; 2019 May; 19(1):140. PubMed ID: 31064371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Individual cognitive stimulation therapy for dementia: a clinical effectiveness and cost-effectiveness pragmatic, multicentre, randomised controlled trial.
    Orgeta V; Leung P; Yates L; Kang S; Hoare Z; Henderson C; Whitaker C; Burns A; Knapp M; Leroi I; Moniz-Cook ED; Pearson S; Simpson S; Spector A; Roberts S; Russell IT; de Waal H; Woods RT; Orrell M
    Health Technol Assess; 2015 Aug; 19(64):1-108. PubMed ID: 26292178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Group cognitive-behavioural programme to reduce the impact of rheumatoid arthritis fatigue: the RAFT RCT with economic and qualitative evaluations.
    Hewlett S; Almeida C; Ambler N; Blair PS; Choy E; Dures E; Hammond A; Hollingworth W; Kadir B; Kirwan J; Plummer Z; Rooke C; Thorn J; Turner N; Pollock J
    Health Technol Assess; 2019 Oct; 23(57):1-130. PubMed ID: 31601357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are the effects of cognitive remediation therapy (CRT) durable? Results from an exploratory trial in schizophrenia.
    Wykes T; Reeder C; Williams C; Corner J; Rice C; Everitt B
    Schizophr Res; 2003 Jun; 61(2-3):163-74. PubMed ID: 12729868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomised controlled trial of computerised cognitive behaviour therapy for the treatment of depression in primary care: the Randomised Evaluation of the Effectiveness and Acceptability of Computerised Therapy (REEACT) trial.
    Littlewood E; Duarte A; Hewitt C; Knowles S; Palmer S; Walker S; Andersen P; Araya R; Barkham M; Bower P; Brabyn S; Brierley G; Cooper C; Gask L; Kessler D; Lester H; Lovell K; Muhammad U; Parry G; Richards DA; Richardson R; Tallon D; Tharmanathan P; White D; Gilbody S;
    Health Technol Assess; 2015 Dec; 19(101):viii, xxi-171. PubMed ID: 26685904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does change in cognitive function predict change in costs of care for people with a schizophrenia diagnosis following cognitive remediation therapy?
    Reeder C; Harris V; Pickles A; Patel A; Cella M; Wykes T
    Schizophr Bull; 2014 Nov; 40(6):1472-81. PubMed ID: 24682210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive remediation therapy (CRT) for young early onset patients with schizophrenia: an exploratory randomized controlled trial.
    Wykes T; Newton E; Landau S; Rice C; Thompson N; Frangou S
    Schizophr Res; 2007 Aug; 94(1-3):221-30. PubMed ID: 17524620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of age and cognitive reserve on cognitive remediation therapy outcome in patients with schizophrenia.
    Kontis D; Huddy V; Reeder C; Landau S; Wykes T
    Am J Geriatr Psychiatry; 2013 Mar; 21(3):218-30. PubMed ID: 23395189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized controlled trial of cognitive remediation for a national cohort of forensic patients with schizophrenia or schizoaffective disorder.
    O'Reilly K; Donohoe G; O'Sullivan D; Coyle C; Corvin A; O'Flynn P; O'Donnell M; Galligan T; O'Connell P; Kennedy HG
    BMC Psychiatry; 2019 Jan; 19(1):27. PubMed ID: 30646884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropsychological predictors of functional outcome in Cognitive Behavioral Social Skills Training for older people with schizophrenia.
    Granholm E; McQuaid JR; Link PC; Fish S; Patterson T; Jeste DV
    Schizophr Res; 2008 Mar; 100(1-3):133-43. PubMed ID: 18222648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Group cognitive rehabilitation to reduce the psychological impact of multiple sclerosis on quality of life: the CRAMMS RCT.
    Lincoln NB; Bradshaw LE; Constantinescu CS; Day F; Drummond AE; Fitzsimmons D; Harris S; Montgomery AA; das Nair R
    Health Technol Assess; 2020 Jan; 24(4):1-182. PubMed ID: 31934845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Manualised cognitive-behavioural therapy in treating depression in advanced cancer: the CanTalk RCT.
    Serfaty M; King M; Nazareth I; Moorey S; Aspden T; Tookman A; Mannix K; Gola A; Davis S; Wood J; Jones L
    Health Technol Assess; 2019 May; 23(19):1-106. PubMed ID: 31097078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of working alliance on adherence and outcome in cognitive remediation therapy.
    Huddy V; Reeder C; Kontis D; Wykes T; Stahl D
    J Nerv Ment Dis; 2012 Jul; 200(7):614-9. PubMed ID: 22759940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive remediation therapy in schizophrenia: randomised controlled trial.
    Wykes T; Reeder C; Landau S; Everitt B; Knapp M; Patel A; Romeo R
    Br J Psychiatry; 2007 May; 190():421-7. PubMed ID: 17470957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Schizophrenia patients with cognitive deficits: factors associated with costs.
    Patel A; Everitt B; Knapp M; Reeder C; Grant D; Ecker C; Wykes T
    Schizophr Bull; 2006 Oct; 32(4):776-85. PubMed ID: 16885205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive-behavioural therapy for clozapine-resistant schizophrenia: the FOCUS RCT.
    Morrison AP; Pyle M; Gumley A; Schwannauer M; Turkington D; MacLennan G; Norrie J; Hudson J; Bowe S; French P; Hutton P; Byrne R; Syrett S; Dudley R; McLeod HJ; Griffiths H; Barnes TR; Davies L; Shields G; Buck D; Tully S; Kingdon D
    Health Technol Assess; 2019 Feb; 23(7):1-144. PubMed ID: 30806619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychopathologic, neuropsychological and functional outcome measures during cognitive rehabilitation in schizophrenia: a prospective controlled study in a real-world setting.
    Vita A; De Peri L; Barlati S; Cacciani P; Cisima M; Deste G; Cesana BM; Sacchetti E
    Eur Psychiatry; 2011; 26(5):276-83. PubMed ID: 20561768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive remediation therapy in adolescents with early-onset schizophrenia: a randomized controlled trial.
    Puig O; Penadés R; Baeza I; De la Serna E; Sánchez-Gistau V; Bernardo M; Castro-Fornieles J
    J Am Acad Child Adolesc Psychiatry; 2014 Aug; 53(8):859-68. PubMed ID: 25062593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].
    Llorca PM; Miadi-Fargier H; Lançon C; Jasso Mosqueda G; Casadebaig F; Philippe A; Guillon P; Mehnert A; Omnès LF; Chicoye A; Durand-Zaleski I
    Encephale; 2005; 31(2):235-46. PubMed ID: 15959450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.